Literature DB >> 30218677

Hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Who, when, and how?

Luigi D Notarangelo1.   

Abstract

Entities:  

Keywords:  Activated phosphoinositide 3-kinase δ syndrome; hematopoietic stem cell transplantation; immune dysregulation; lymphocyte metabolism

Mesh：

Substances：

Year:  2018        PMID： 30218677      PMCID： PMC6643100          DOI： 10.1016/j.jaci.2018.08.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.

Authors:  Zohreh Nademi; Mary A Slatter; Christopher C Dvorak; Benedicte Neven; Alain Fischer; Felipe Suarez; Claire Booth; Kanchan Rao; Alexandra Laberko; Julia Rodina; Yves Bertrand; Sylwia Kołtan; Robert Dębski; Terence Flood; Mario Abinun; Andrew R Gennery; Sophie Hambleton; Stephan Ehl; Andrew J Cant
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

2.  Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

Authors:  Tsubasa Okano; Kohsuke Imai; Yuki Tsujita; Noriko Mitsuiki; Kenichi Yoshida; Chikako Kamae; Kenichi Honma; Kanako Mitsui-Sekinaka; Yujin Sekinaka; Tamaki Kato; Katsuyuki Hanabusa; Eri Endo; Takehiro Takashima; Haruka Hiroki; Tzu-Wen Yeh; Keisuke Tanaka; Masakazu Nagahori; Ikuya Tsuge; Yuki Bando; Fuminori Iwasaki; Yoshiaki Shikama; Masami Inoue; Tomiko Kimoto; Naohiko Moriguchi; Yuki Yuza; Takashi Kaneko; Kyoko Suzuki; Tomoyo Matsubara; Yoshihiro Maruo; Tomoaki Kunitsu; Tomoko Waragai; Hideki Sano; Yuko Hashimoto; Kazuhiro Tasaki; Osamu Suzuki; Toshihiko Shirakawa; Motohiro Kato; Toru Uchiyama; Masataka Ishimura; Tetsuzo Tauchi; Hiroshi Yagasaki; Shiann-Tarng Jou; Hsin-Hui Yu; Hirokazu Kanegane; Sven Kracker; Anne Durandy; Daiei Kojima; Hideki Muramatsu; Taizo Wada; Yuzaburo Inoue; Hidetoshi Takada; Seiji Kojima; Seishi Ogawa; Osamu Ohara; Shigeaki Nonoyama; Tomohiro Morio
Journal:  J Allergy Clin Immunol       Date:  2018-05-18       Impact factor: 10.793

3.  Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Authors:  Carrie L Lucas; Hye Sun Kuehn; Fang Zhao; Julie E Niemela; Elissa K Deenick; Umaimainthan Palendira; Danielle T Avery; Leen Moens; Jennifer L Cannons; Matthew Biancalana; Jennifer Stoddard; Weiming Ouyang; David M Frucht; V Koneti Rao; T Prescott Atkinson; Anahita Agharahimi; Ashleigh A Hussey; Les R Folio; Kenneth N Olivier; Thomas A Fleisher; Stefania Pittaluga; Steven M Holland; Jeffrey I Cohen; Joao B Oliveira; Stuart G Tangye; Pamela L Schwartzberg; Michael J Lenardo; Gulbu Uzel
Journal:  Nat Immunol       Date:  2013-10-28       Impact factor: 25.606

4.  Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.

Authors:  V Koneti Rao; Sharon Webster; Virgil A S H Dalm; Anna Šedivá; P Martin van Hagen; Steven Holland; Sergio D Rosenzweig; Andreas D Christ; Birgitte Sloth; Maciej Cabanski; Aniket D Joshi; Stefan de Buck; Julie Doucet; Danilo Guerini; Christoph Kalis; Ilona Pylvaenaeinen; Nicolas Soldermann; Anuj Kashyap; Gulbu Uzel; Michael J Lenardo; Dhavalkumar D Patel; Carrie L Lucas; Christoph Burkhart
Journal:  Blood       Date:  2017-09-29       Impact factor: 22.113

5.  Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.

Authors:  Mara Compagno; Qi Wang; Chiara Pighi; Taek-Chin Cheong; Fei-Long Meng; Teresa Poggio; Leng-Siew Yeap; Elif Karaca; Rafael B Blasco; Fernanda Langellotto; Chiara Ambrogio; Claudia Voena; Adrian Wiestner; Siddha N Kasar; Jennifer R Brown; Jing Sun; Catherine J Wu; Monica Gostissa; Frederick W Alt; Roberto Chiarle
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

Review 6.  Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy.

Authors:  David Michalovich; Sergey Nejentsev
Journal:  Front Immunol       Date:  2018-02-27       Impact factor: 7.561

7.  Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry.

Authors:  Maria Elena Maccari; Hassan Abolhassani; Asghar Aghamohammadi; Alessandro Aiuti; Olga Aleinikova; Catherine Bangs; Safa Baris; Federica Barzaghi; Helen Baxendale; Matthew Buckland; Siobhan O Burns; Caterina Cancrini; Andrew Cant; Pascal Cathébras; Marina Cavazzana; Anita Chandra; Francesca Conti; Tanya Coulter; Lisa A Devlin; J David M Edgar; Saul Faust; Alain Fischer; Marina Garcia-Prat; Lennart Hammarström; Maximilian Heeg; Stephen Jolles; Elif Karakoc-Aydiner; Gerhard Kindle; Ayca Kiykim; Dinakantha Kumararatne; Bodo Grimbacher; Hilary Longhurst; Nizar Mahlaoui; Tomas Milota; Fernando Moreira; Despina Moshous; Anna Mukhina; Olaf Neth; Benedicte Neven; Alexandra Nieters; Peter Olbrich; Ahmet Ozen; Jana Pachlopnik Schmid; Capucine Picard; Seraina Prader; William Rae; Janine Reichenbach; Stephan Rusch; Sinisa Savic; Alessia Scarselli; Raphael Scheible; Anna Sediva; Svetlana O Sharapova; Anna Shcherbina; Mary Slatter; Pere Soler-Palacin; Aurelie Stanislas; Felipe Suarez; Francesca Tucci; Annette Uhlmann; Joris van Montfrans; Klaus Warnatz; Anthony Peter Williams; Phil Wood; Sven Kracker; Alison Mary Condliffe; Stephan Ehl
Journal:  Front Immunol       Date:  2018-03-16       Impact factor: 7.561

Review 8.  PI3Kδ and primary immunodeficiencies.

Authors:  Carrie L Lucas; Anita Chandra; Sergey Nejentsev; Alison M Condliffe; Klaus Okkenhaug
Journal:  Nat Rev Immunol       Date:  2016-09-12       Impact factor: 53.106

9.  Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

Authors:  Tanya I Coulter; Anita Chandra; Chris M Bacon; Judith Babar; James Curtis; Nick Screaton; John R Goodlad; George Farmer; Cathal Laurence Steele; Timothy Ronan Leahy; Rainer Doffinger; Helen Baxendale; Jolanta Bernatoniene; J David M Edgar; Hilary J Longhurst; Stephan Ehl; Carsten Speckmann; Bodo Grimbacher; Anna Sediva; Tomas Milota; Saul N Faust; Anthony P Williams; Grant Hayman; Zeynep Yesim Kucuk; Rosie Hague; Paul French; Richard Brooker; Peter Forsyth; Richard Herriot; Caterina Cancrini; Paolo Palma; Paola Ariganello; Niall Conlon; Conleth Feighery; Patrick J Gavin; Alison Jones; Kohsuke Imai; Mohammad A A Ibrahim; Gašper Markelj; Mario Abinun; Frédéric Rieux-Laucat; Sylvain Latour; Isabelle Pellier; Alain Fischer; Fabien Touzot; Jean-Laurent Casanova; Anne Durandy; Siobhan O Burns; Sinisa Savic; D S Kumararatne; Despina Moshous; Sven Kracker; Bart Vanhaesebroeck; Klaus Okkenhaug; Capucine Picard; Sergey Nejentsev; Alison M Condliffe; Andrew James Cant
Journal:  J Allergy Clin Immunol       Date:  2016-07-16       Impact factor: 10.793

10.  Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.

Authors:  Elodie Elkaim; Benedicte Neven; Julie Bruneau; Kanako Mitsui-Sekinaka; Aurelie Stanislas; Lucie Heurtier; Carrie L Lucas; Helen Matthews; Marie-Céline Deau; Svetlana Sharapova; James Curtis; Janine Reichenbach; Catherine Glastre; David A Parry; Gururaj Arumugakani; Elizabeth McDermott; Sara Sebnem Kilic; Motoi Yamashita; Despina Moshous; Hicham Lamrini; Burkhard Otremba; Andrew Gennery; Tanya Coulter; Isabella Quinti; Jean-Louis Stephan; Vassilios Lougaris; Nicholas Brodszki; Vincent Barlogis; Takaki Asano; Lionel Galicier; David Boutboul; Shigeaki Nonoyama; Andrew Cant; Kohsuke Imai; Capucine Picard; Sergey Nejentsev; Thierry Jo Molina; Michael Lenardo; Sinisa Savic; Marina Cavazzana; Alain Fischer; Anne Durandy; Sven Kracker
Journal:  J Allergy Clin Immunol       Date:  2016-04-21       Impact factor: 10.793
  10 in total
  3 in total

Review 1.  Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know.

Authors:  Saniya Sharma; Rakesh Kumar Pilania; Gummadi Anjani; Murugan Sudhakar; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 2.  Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.

Authors:  Stephen A Schworer; Olivia L Francis; Steven M Johnson; Benjamin D Smith; Stuart H Gold; Andrew B Smitherman; Eveline Y Wu
Journal:  J Pediatr Hematol Oncol       Date:  2021-11-01       Impact factor: 1.289

3.  International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.

Authors:  Dimana Dimitrova; Zohreh Nademi; Maria Elena Maccari; Stephan Ehl; Gulbu Uzel; Takahiro Tomoda; Tsubasa Okano; Kohsuke Imai; Benjamin Carpenter; Winnie Ip; Kanchan Rao; Austen J J Worth; Alexandra Laberko; Anna Mukhina; Bénédicte Néven; Despina Moshous; Carsten Speckmann; Klaus Warnatz; Claudia Wehr; Hassan Abolhassani; Asghar Aghamohammadi; Jacob J Bleesing; Jasmeen Dara; Christopher C Dvorak; Sujal Ghosh; Hyoung Jin Kang; Gašper Markelj; Arunkumar Modi; Diana K Bayer; Luigi D Notarangelo; Ansgar Schulz; Marina Garcia-Prat; Pere Soler-Palacín; Musa Karakükcü; Ebru Yilmaz; Eleonora Gambineri; Mariacristina Menconi; Tania N Masmas; Mette Holm; Carmem Bonfim; Carolina Prando; Stephen Hughes; Stephen Jolles; Emma C Morris; Neena Kapoor; Sylwia Koltan; Shankara Paneesha; Colin Steward; Robert Wynn; Ulrich Duffner; Andrew R Gennery; Arjan C Lankester; Mary Slatter; Jennifer A Kanakry
Journal:  J Allergy Clin Immunol       Date:  2021-05-24       Impact factor: 10.793
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.